On this page
⚠ Educational content only Not medical or genetic advice. Speak with a healthcare provider or genetic counsellor before acting on anything here.

PYGM

glycogen phosphorylase, muscle associated

The PYGM gene encodes myophosphorylase, an enzyme essential for glycogen breakdown in muscle cells, with pathogenic variants causing Glycogen Storage Disease Type V (GSD V). PYGM provides instructions for an enzyme called myophosphorylase, which is vital for energy production in muscle cells.

Chromosome 11q13.1 Autosomal recessive HGNC:9726 Tier C
PYGM 11q13.1 p arm q arm 11

PYGM is located on the long (q) arm of chromosome 11, at band 11q13.1. Arm ratio per GRCh38 - banding schematic.

Explore chromosome 11 in the library →

Available at Jeen Health

Clinical tests that include this

Overview

The PYGM gene, or glycogen phosphorylase, muscle associated, is responsible for producing the myophosphorylase enzyme. This enzyme plays a critical role in carbohydrate metabolism, specifically within muscle tissues. Myophosphorylase facilitates the breakdown of glycogen, a stored form of glucose, into a readily usable sugar for muscle energy.

Disruptions to the PYGM gene's function can lead to an inability of muscle cells to adequately break down glycogen, resulting in an accumulation of glycogen and impaired energy supply. This genetic alteration forms the basis of Glycogen Storage Disease Type V.

What the gene does

The PYGM gene instructs the synthesis of myophosphorylase, one of three related glycogen phosphorylase enzymes. Myophosphorylase is specifically expressed in muscle cells, where it functions to break down glycogen, a complex carbohydrate, into glucose-1-phosphate. This process is the initial step in converting stored glycogen into glucose, which serves as the primary energy source for cellular functions.

Glycogen breakdown is crucial for muscles, especially during physical activity, to maintain a continuous supply of energy. Myophosphorylase ensures that muscle cells can rapidly access their stored energy reserves by converting glycogen into a form that can enter metabolic pathways to produce ATP, the cell's main energy currency. A deficiency in this enzyme significantly impacts muscle energy metabolism.

Video: Genetics 101

Chromosome location

The PYGM gene is situated on chromosome 11, specifically at the band 11q13.1. This location indicates its position on the long (q) arm of chromosome 11. The gene provides the genetic blueprint for a protein composed of 842 amino acids.

Protein structure

Domain architecture has not been experimentally characterised in detail for this protein.

Key variants

Variations within the PYGM gene can affect the production or function of the myophosphorylase enzyme. These genetic changes can range from single nucleotide substitutions to larger deletions or insertions, and their impact varies depending on the specific alteration. Pathogenic variants can lead to a reduction in enzyme activity or complete absence of the protein.

The table below shows the top 10 pathogenic or likely-pathogenic variants currently classified in ClinVar for PYGM.
View all on ClinVar →

Sample of pathogenic variants

10 pathogenic / likely-pathogenic variants from ClinVar, ranked by review status (expert-panel-reviewed first). This is a sample; recurrent founder variants in a specific population may not appear here - see the full ClinVar listing via the link above.

Variant (HGVS) Protein change Classification Evidence Associated condition
c.125del
Deletion
p.Lys42fs Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type V
c.134del
Deletion
p.Asn45fs Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type V
c.1363G>C
single nucleotide variant
p.Gly455Arg Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type V
c.2040_2041insCC
Insertion
p.Lys681fs Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type V
c.2075_2076delinsAAA
Indel
p.Thr692fs Pathogenic ★★☆☆ Glycogen storage disease, type V
c.2146dup
Duplication
p.Val716fs Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type V
c.485_486del
Deletion
p.Arg161_Tyr162insTer Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type V
c.505C>T
single nucleotide variant
p.Gln169Ter Pathogenic ★★☆☆ Glycogen storage disease, type V
c.580del
Deletion
p.Arg194fs Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type V
c.658C>T
single nucleotide variant
p.Gln220Ter Pathogenic/Likely pathogenic ★★☆☆ Glycogen storage disease, type V

Evidence stars indicate ClinVar review status. Individual variant interpretation should always be performed by a qualified clinical laboratory - many variants remain classified as Variants of Uncertain Significance (VUS) pending more research.

Associated conditions

Pathogenic variants in the PYGM gene are primarily associated with Glycogen Storage Disease Type V (GSD V), also known as McArdle disease. This condition is inherited in an autosomal recessive pattern. Individuals with GSD V typically experience muscle pain, stiffness, and fatigue, particularly during exercise, due to the muscles' inability to properly break down glycogen for energy.

Inheritance pattern

Conditions caused by pathogenic PYGM variants typically follow autosomal recessive inheritance.

♀ Carrier parent 1 altered copy ♂ Carrier parent 1 altered copy Affected Carrier Carrier Unaffected Affected Carrier Unaffected Circles = females · Squares = males

When both parents are carriers, each child has a 25% chance of being affected, 50% of being a carrier, and 25% of being unaffected.

Carrier frequency by population How common is heterozygous PYGM carrier status across ancestry groups?

UK clinical status

The PYGM gene is included on several NHS Genomic Medicine Service clinical panels, indicating its relevance in diagnosing specific inherited conditions within the UK. It is featured on panels for Acute rhabdomyolysis, Foetal anomalies, Glycogen storage disease, Glycogen storage disease V, Hyperammonaemia, Likely inborn error of metabolism, Limb girdle muscular dystrophies, myofibrillar myopathies and distal myopathies, Retinal disorders, Rhabdomyolysis and metabolic muscle disorders, Skeletal Muscle Channelopathies, Skeletal muscle channelopathy, and Undiagnosed metabolic disorders.

Frequently asked questions

What is the role of the PYGM gene?

The PYGM gene provides instructions for making myophosphorylase, an enzyme found in muscle cells. This enzyme is crucial for breaking down glycogen into a usable sugar, which powers muscle activity, especially during exercise.

What health condition is linked to the PYGM gene?

Variants in the PYGM gene are associated with Glycogen Storage Disease Type V (GSD V), also known as McArdle disease. This condition affects the muscles' ability to use stored glycogen for energy, leading to symptoms like muscle pain and fatigue during physical activity.

How is Glycogen Storage Disease Type V inherited?

Glycogen Storage Disease Type V (GSD V) is inherited in an autosomal recessive pattern. This means an individual must inherit two altered copies of the PYGM gene, one from each parent, to develop the condition. Individuals with only one altered copy are typically carriers and do not show symptoms.

References

  1. Nogales-Gadea G, Rubio JC, Fernandez-Cadenas I. Expression of the muscle glycogen phosphorylase gene in patients with McArdle disease: the role of nonsense-mediated mRNA decay. Human mutation. 2008. PMID: 17994553
  2. Nogales-Gadea G, Arenas J, Andreu AL. Molecular genetics of McArdle's disease. Current neurology and neuroscience reports. 2007. PMID: 17217859
  3. Aquaron R, Bergé-Lefranc JL, Pellissier JF. Molecular characterization of myophosphorylase deficiency (McArdle disease) in 34 patients from Southern France: identification of 10 new mutations. Absence of genotype-phenotype correlation. Neuromuscular disorders : NMD. 2007. PMID: 17324573
  4. Deschauer M, Morgenroth A, Joshi PR. Analysis of spectrum and frequencies of mutations in McArdle disease. Identification of 13 novel mutations. Journal of neurology. 2007. PMID: 17404776
  5. Bruno C, Cassandrini D, Martinuzzi A. McArdle disease: the mutation spectrum of PYGM in a large Italian cohort. Human mutation. 2006. PMID: 16786513
Educational content. This page is not medical or genetic advice, is not individually reviewed by a clinician for each reader, and should not replace a consultation with a qualified healthcare professional or genetic counsellor. If you are considering genetic testing or acting on a test result, book a consultation.
Data sources Last updated 18 October 2026. Content compiled from HGNC · MedlinePlus Genetics · ClinGen · Genomics England PanelApp · NHS National Genomic Test Directory · ClinVar · UniProt · AlphaFold .